Omega 3 fatty acids in dry eye syndrome
- Conditions
- Dry Eye Syndrome
- Registration Number
- JPRN-UMIN000049192
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 450
Not provided
Patients with allergic conjunctivitis, history of laser in situ keratomileusis, and contact lens wear, or other causes of dry eye in the office-going population, software professionals, or university students were excluded from the study. Patients with inability to swallow soft-gel capsules, those on regular course of aspirin or anticoagulants (cyclooxygenase-2 inhibitors), and those allergic to fluorescein were also excluded. Systemic (tetracyclines and corticosteroids) or topical medications (other than artificial tear supplements) that could affect the tear film or meibomian gland functions (betablockers, benzodiazepines, and antihistamines) were discontinued 3 weeks before intervention. Moreover, patients were instructed not to use artificial tear preparations, 2 hr before testing.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method